Prima Mente

Seed
primamente.com Biotech & Healthcare United Kingdom
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Apr 16, 2026
Investors 1 Backer
Decision Makers Profile Active

About Prima Mente

CFDX aims to apply the liquid biopsy techniques used in early cancer detection to neurodegenerative diseases, enabling diagnosis decades before symptoms appear.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters United Kingdom
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website primamente.com
Domain Registered Date Jan 28, 2025

Social & Network Presence

X / Twitter Profile @PrimaMente (1.1K followers) Created on Mar 2025
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Seed announced

  2. Milestone

    X account created (@PrimaMente)

    1.1K followers

  3. Milestone

    Website domain registered

    primamente.com

Investors & Backers

1
Antler

Funding History

2 Rounds
Seed · Apr 16, 2026
Undisclosed
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

1

Jonathan Wan

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts